1-3 of 3
Dramane Laine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Asciminib in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Results from the Phase 2 ASC2ESCALATE Trial in the Cohort of Patients (Pts) after 1 Prior Tyrosine Kinase Inhibitor (TKI)

Ehab L. Atallah, Moshe Y. Levy, Paul B. Koller, Koji Sasaki, Srinivas K Tantravahi, David Andorsky, Celesteann T Bremer, Joshua F Zeidner, Marlise R. Luskin, Reinhold Munker, Daisy Yang, Dramane Laine, John Sabo, Ennan Gu, Michael J. Mauro, Jorge E. Cortes
Journal: Blood
Blood (2024) 144 (Supplement 1): 479.
https://doi.org/10.1182/blood-2024-200717
Published: 2024
Journal Articles

ASC2ESCALATE: A US Phase 2, Open-Label, Single-Arm, Dose-Escalation Study of Asciminib (ASC) Monotherapy in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) As Second-Line (2L) and First-Line (1L) Treatment

Ehab L. Atallah, Michael Mauro, Koji Sasaki, Moshe Levy, Paul B. Koller, Daisy Yang, Dramane Laine, John Sabo, Ennan GU, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 6389.
https://doi.org/10.1182/blood-2023-186974
Published: 2023
Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Modupe Idowu, Michael R. DeBaun, Arthur Burnett, Deepika S. Darbari, Soheir Adam, Alan Randall Anderson, Julie Kanter, Henny H. Billett, Darla K. Liles, Robert S. Nickel, Laura M. Decastro, Biree Andemariam, Gershwin Theophilus Blyden, Matthew M. Heeney, Poornima Ramadas, Morgan L. McLemore, Yogita Kolekar, Dramane Laine, Jincy Paulose, Rajendra Sarkar, Mary Beth Vignogna, Fuad El Rassi
Journal: Blood
Blood (2023) 142 (Supplement 1): 146.
https://doi.org/10.1182/blood-2023-179042
Published: 2023